首页> 外文期刊>Canada communicable disease report =: Relev?des maladies transmissibles au Canada >An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)*?
【24h】

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)*?

机译:咨询委员会声明(ACS)国家免疫咨询委员会(NACI)* ?

获取原文
       

摘要

The National Advisory Committee on Immunization (NACI) provides the Public Health Agency of Canada with ongoing and timely medical, scientific, and public health advice relating to immunization. The Public Health Agency of Canada acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and is disseminating this document for information purposes. People administering the vaccine should also be aware of the contents of the relevant product monograph(s). Recommendations for use and other information set out herein may differ from that set out in the product monograph(s) of the Canadian manufacturer(s) of the vaccine(s). Manufacturer(s) have sought approval of the vaccine(s) and provided evidence as to its safety and efficacy only when it is used in accordance with the product monographs. NACI members and liaison members conduct themselves within the context of the Public Health Agency of Canada's Policy on Conflict of Interest, including yearly declaration of potential conflict of interest.
机译:全国免疫咨询委员会(NACI)为加拿大公共卫生局提供有关免疫的持续,及时的医学,科学和公共卫生建议。加拿大公共卫生局承认,本声明中提出的建议和建议是基于当前可获得的最佳科学知识,并且正在分发本文档以供参考。接种疫苗的人员还应了解相关产品专论的内容。本文中提出的使用建议和其他信息可能与加拿大疫苗生产商的产品专论中列出的建议有所不同。制造商寻求疫苗的批准,并仅在按照产品专论使用时提供有关其安全性和有效性的证据。 NACI成员和联络成员在加拿大公共卫生局《利益冲突政策》的范围内行事,包括每年宣布潜在的利益冲突。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号